April 05, 2022

A successful nursing career requires resiliency in the face of uncertainty, Susan Orsega, MSN, FNP-BC, FAANP, FAAN, director of the Commissioned Corps Headquarters, said during a career forum hosted by the National Institute of Neurological Disorders and Stroke’s (NINDS’s) Building Engagement and Community for Nurses (BEACON) program in February 2022. She joined a plethora of nurse pioneers at the forum to share ways that nurses can collaborate and make significant contributions to and grow professionally in the nursing field.

April 05, 2022

On April 1, 2022, the U.S. Food and Drug Administration (FDA) approved axicabtagene ciloleucel (Yescarta®) for adult patients with large B-cell lymphoma (LBCL) that is refractory to first-line chemoimmunotherapy or relapses within 12 months of first-line chemoimmunotherapy. It is not indicated for the treatment of patients with primary central nervous system lymphoma.

April 05, 2022

Ambulatory oncology began to gradually evolve in the mid-2000s to include multiple aspects of the care continuum. Then suddenly, a pandemic skyrocketed that growth as institutions Raced to develop their ambulatory infrastructure to meet new and changing needs.

April 04, 2022

Governing ONS—including fiduciary oversight for all investments and budgets and strategic decision-making that secures the future of the organization—is the ONS Board of Directors’ primary role. In even the best of times, it is a serious commitment to govern our complex association, but the unpredictable environment we have experienced since early 2020 has increased that challenge.

March 30, 2022

Regular, light-intensity exercise and activity has been shown to reduce the risks of fractures, heart disease, and death. Substantial evidence also indicated benefits for cancer-related outcomes, including fatigue, depression, and quality of life. Additional observational data suggested that sustained physical activity may help reduce cancer recurrence and improve overall survival.

March 29, 2022

As many as 49% of patients with cancer are at risk for clinically significant levels of anxiety and 38% are at risk for clinically significant levels of depression, according to data collected through the Cancer Support Community’s (CSC’s) cancer experience registry. Additionally, nearly half of caregivers have anxiety levels that are substantially higher than the national average and one-third face substantially higher fatigue and depression levels. Nationally, the rates for levels of anxiety and depression are 19.1% of U.S. adults aged 18 and older and 8.4% of U.S.